Effects of SGLT2 inhibitors on liver stiffness in type 2 diabetes patients with MASLD and moderate-to-advanced fibrosis risk
Ege Tıp Dergisi · 10.06.2026 · 65 (2) · 295-304
DOI: 10.19161/etd.1885126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ege Tıp Dergisi, online erschienen am 10.06.2026. Verfasst von Utku Erdem Soyaltin und 4 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Gefördert von: none.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Patients with type 2 diabetes mellitus (T2DM) and metabolic dysfunction–associated steatotic liver disease (MASLD) with moderate-to-advanced fibrosis risk have limited therapeutic options. We evaluated the effects of sodium–glucose cotransporter 2 inhibitors (SGLT2i) compared with other antidiabetic agents on liver stiffness in this high-risk population.Material and Methods: This retrospective study included 37 patients with T2DM and MASLD with baseline liver stiffness ≥8 kPa assessed by vibration-controlled transient elastography. Twenty-one patients received empagliflozin and 16 received other antidiabetic agents (DPP-4 inhibitors, sulfonylureas, or insulin). Liver stiffness (primary endpoint), HbA1c, body mass index (BMI), and FIB-4 were evaluated at baseline and after 24 weeks.
Results
Liver stiffness decreased significantly in both groups (SGLT2i: 11.16→7.47 kPa, p
Förderung
- none
Zitieren
APA
Soyaltin, U. E., Aliyeva, N., Balta, C., Çelebi, T., & Şimşir, I. Y. (2026). Effects of SGLT2 inhibitors on liver stiffness in type 2 diabetes patients with MASLD and moderate-to-advanced fibrosis risk. Ege Tıp Dergisi, 65(2), 295-304. https://doi.org/10.19161/etd.1885126
Vancouver
Soyaltin UE, Aliyeva N, Balta C, Çelebi T, Şimşir IY. Effects of SGLT2 inhibitors on liver stiffness in type 2 diabetes patients with MASLD and moderate-to-advanced fibrosis risk. Ege Tıp Dergisi. 2026;65(2):295-304. doi:10.19161/etd.1885126
BibTeX
@article{Soyaltin2026,
author = {Soyaltin, Utku Erdem and Aliyeva, Nurana and Balta, Cem and Çelebi, Tuğba and Şimşir, Ilgın Yıldırım},
title = {Effects of SGLT2 inhibitors on liver stiffness in type 2 diabetes patients with MASLD and moderate-to-advanced fibrosis risk},
journal = {Ege Tıp Dergisi},
year = {2026},
volume = {65},
number = {2},
pages = {295--304},
doi = {10.19161/etd.1885126}
}
EUVIMED